Nova Leap Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, net loss was USD 0.41442 million compared to net income of USD 1.23 million a year ago. Basic loss per share from continuing operations was USD 0.005 compared to basic earnings per share from continuing operations of USD 0.017 a year ago. Diluted loss per share from continuing operations was USD 0.005 compared to diluted earnings per share from continuing operations of USD 0.017 a year ago.